SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain

E-ISSN： 1874-4702|6|2|66-73

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.6, Iss.2, 2013-07, pp. : 66-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diseases Associated with General Amino Acid Transporters of the Solute Carrier 6 Family (SLC6)

Current Molecular Pharmacology, Vol. 6, Iss. 2, 2013-07 ,pp. : 74-87

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 9, Iss. 8, 2003-03 ,pp. : 599-625

Bentham Science Publishers

Access to resources Recommend Favorite

Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological Roles

By Rizwan Ahsan Burckhardt Gerhard

Pharmaceutical Research, Vol. 24, Iss. 3, 2007-03 ,pp. : 450-470

Springer Publishing Company

Access to resources Recommend Favorite

The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. : 2843-2851

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting CNS Transporters for Treatment of Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1523-1533

Bentham Science Publishers

Access to resources Recommend Favorite